6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Compulsive Drug Seeking Behavior
Compulsive drug-seeking behavior is a hallmark of addiction, driven by changes in the brain's reward and stress systems. This behavior persists despite negative consequences, reflecting an overpowering need to obtain and use substances. Neurobiological factors, such as heightened dopamine responses, reinforce the urge to seek drugs, while emotional triggers and environmental cues further exacerbate the cycle. Addressing compulsive behavior involves a combination of therapies, including CBT, which helps individuals identify and modify thought patterns, and medication-assisted treatment (MAT) to reduce cravings. A holistic approach targeting both the physiological and psychological aspects is essential to breaking this cycle and supporting recovery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States